SCHEMBL7575302

SCHEMBL7575302

CCc1ccccc1-c1cc(C=O)ccc1C#N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.38
RXFP1 Q9HBX9 1/20 0.36
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35
CSNK2A3 Q8NEV1 1/20 0.35
USP8 P40818 1/20 0.35
USP7 Q93009 1/20 0.35
ALDH1A1 P00352 4/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KIF11 P52732 2/20 0.33
PDE10A Q9Y233 1/20 0.33
HTR2A P28223 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GALR3 O60755 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7570617 0.82 AR (0.44) ARUSP8USP7ALDH1A1KDM4E
SCHEMBL13571237 0.79 ALDH1A1 (0.39) ARALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL27762059 0.79 ESR2 (0.44) ARCSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL7577589 0.79 KDM4E (0.43) ARUSP8USP7ALDH1A1NPC1
SCHEMBL7571007 0.78 USP8 (0.37) ARRXFP1USP8USP7ALDH1A1
SCHEMBL7577326 0.78 AR (0.48) ARRXFP1ALDH1A1MAPTSMN1; SMN2
SCHEMBL8406781 0.77 ALDH1A1 (0.47) RXFP1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL7571276 0.77 TSHR (0.37) ARUSP8USP7ALDH1A1MAPT
SCHEMBL7569269 0.77 CSNK2A2 (0.41) ARCSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL7576912 0.77 MCL1 (0.47) ALDH1A1KIF11KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 AR 4525/4885RXFP1 2904/4885CSNK2A2 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.